Liver injury in α1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
α1-Antitrypsin (α1AT), the archetype of the Serpin supergene family, is the principal blood-borne inhibitor of destructive neutrophil proteases including elastase, cathepsin G, and proteinase 3 (reviewed in ref. 1). This glycoprotein, is secreted by liver cells and is considered an acute-phase reactant because its plasma levels increase during the host response to inflammation/tissue injury. The classical form of α1AT deficiency, which affects 1 in 1,800 live births in Northern European and North American populations, is associated with a mutant molecule termed α1ATZ, which is retained as a polymer in the endoplasmic reticulum (ER) of liver cells (reviewed in refs. 2, 3). Homozygotes are predisposed to premature development of pulmonary emphysema by a loss-of-function mechanism in which lack of α1AT in the lung permits uninhibited proteolytic damage to the connective tissue matrix (4, 5). Cigarette smoking markedly increases the risk and rate of development of emphysema (6). One mechanism for this environmental risk factor involves the functional inactivation of residual α1AT by phagocyte-derived active oxygen intermediates (4, 5). However, a growing body of evidence suggests that other environmental factors and genetic traits affect the incidence and severity of lung disease among α1AT-deficient individuals (7). It is still not entirely clear whether heterozygotes for α1ATZ are predisposed to lung disease. Homozygotes for α1ATZ (“PIZZ” individuals) are also at risk for liver disease. In fact, α1AT deficiency is the most common genetic cause of liver disease in children (2, 3), and it predisposes adults to chronic liver disease and hepatocellular carcinoma (8). However, in contrast to the pathobiology of lung disease, liver injury in this deficiency appears to involve a gain-of-function mechanism whereby retention of the mutant α1ATZ molecule in the ER triggers a series of events that are eventually hepatotoxic. The strongest evidence for a gain-of-function mechanism comes from studies in which mice transgenic for mutant human α1ATZ develop liver injury with many of the histopathologic hallmarks of the human condition (9, 10). Because there are normal levels of anti-elastases in these mice, as directed by endogenous genes, the liver injury cannot be attributed to a loss of function. Landmark nationwide prospective screening studies done by Sveger in Sweden have documented an extraordinary variation in the phenotypic expression of liver disease among homozygotes. In these studies, only 10–15% of the PIZZ population developed clinically significant liver disease over the first 20 years of life (11, 12). These data indicate that other genetic traits and/or environmental factors predispose a subgroup of PIZZ individuals to liver injury. Because only a subgroup of homozygotes develop liver disease and because there is an inherent bias in ascertainment in other clinical studies of α1AT deficiency, it has been very difficult to determine whether heterozygous (“PIMZ”) individuals are at increased risk for liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Aggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148
The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol
Ye, Y., Meyer, H. H., & Rapoport, T. A. (2001) · Nature · doi:10.1038/414652a · Cited by 1,099
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., et al. (2000) · Nature · doi:10.1038/35022604 · Cited by 959
Cited by
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331
“…contrast, elevated levels of autophagosome formation were reported in other human pathologies such as neurodegenerative diseases, myopathies, and liver injury (Mizushima et al., 2002; Perlmutter, 2002), and autophagy is implicated in the execution of cell death (Xue et al., 1999; Bursch, 2001).”
BackgroundLC3 conjugation system in mammalian autophagy
Tanida, I., Ueno, T., & Kominami, E. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.05.009 · Cited by 1,461
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.10.001 · Cited by 851
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Heaton, N. S., & Randall, G. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.10.006 · Cited by 705
Regulation and role of autophagy in mammalian cells
Meijer, A. J., & Codogno, P. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.02.002 · Cited by 615
Metadata
- Authors
- Perlmutter, D. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-12-01
- Volume
- 110
- Issue
- 11
- Pages
- 1579-1583
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1964635647
- Cited by
- 150
- References
- 6
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.